secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lakeside Holding Ltd (LSH)
CIK:        0001996192
Form:       8-K
Filed at:   2024-11-08T23:59:59+00:00
Accession:  0001213900-24-095883
Event type: m_and_a
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lakeside subsidiary to acquire 100% of Hupan Pharmaceutical for RMB4M (US$0.6M)
-------------------------------------------------------------------------------

- Lakeside's subsidiary Sichuan Hupan signs deal to acquire 100% of Hupan Pharmaceutical for RMB4.0M (US$0.6M).
- Payment in three installments: 20% prepayment (RMB800K) within 7 days post-signing, 60% after conditions, 20% on completion.
- Sellers Hubei Haoyaoshi (90%) and Hubei Huayao (10%) transfer all equity; no third-party interests.
- Target provides pharmaceutical distribution, supply chain, brand promotion, and healthcare technology support.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1996192/000121390024095883/0001213900-24-095883-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1996192/000121390024095883/ea0220168-8k_lakeside.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-095883

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer